Small organometallic compounds as antibacterial agents

Small organometallic compounds as antibacterial agents.

The emergence of bacterial resistance to commercial antibiotics is an issue of global importance. During the last two decades, the number of antibacterial agents that have been discovered and introduced into the market has steadily declined and failed to meet the challenges posed by rapidly increasing resistance of the pathogens against common antibacterial drugs. The development of new classes...

Study of Some Benzimidazole Compounds as Antibacterial and Antifungal Agents

There is a clinical need for new treatment option as a result of continued increase in the expression of resistance among bacterial and fungal pathogens. A number of compounds currently in development show promise. However, in some cases, there is concern that resistance may develop quickly to new compounds that are based on existing antimicrobial agents. So it is therefore desirable to develop...

Novel Levofloxacin Derivatives as Potent Antibacterial Agents

In this report, a new series of fluoroquinolone agents which was derived from levofloxacin was synthesized and evaluated against Gram-positive (Bacillus subtillis, Staphylococcus aureus, Staphylococcus epidermidis and Micrococcus luteus) and Gram-negative (Esherichio coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Serratia marcescens) organisms. The results showed that some of the synth...

Dendrimers as Antibacterial Agents

Cruciaromaticity in organometallic compounds

A recent suggestion, that transition metal complexes of unsaturated ligands can be regarded as cruciconjugated, is explored by studies of various complexes of Fe(II), the aromaticity of the resulting i systems being analyzed in terms of PMO theory. This approach is also applied to porphyrin. The conclusions are supported by preliminary SCF and MNDO calculations.